Viking Therapeutics beats earnings expectations by $0.06 EPS, stock up $14.27 to $64.68.
Viking Therapeutics (VKTX) announced earnings results that beat expectations by $0.06 EPS, with a reported ($0.20) EPS for the quarter compared to the consensus estimate of ($0.26). The company's stock traded up $14.27 during trading on Thursday, hitting $64.68, and has a market capitalization of $7.13 billion. Analysts at Raymond James increased their price target on shares of VKTX from $116.00 to $118.00.
July 25, 2024
5 Articles